TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07225751: A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing

Sponsor: Kuros Biosurgery AG · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 126 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$398,400

Rescue Site Savings

+$265,600

Unlock Full NCT07225751 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07225751 Rescue Dossier →